SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivanza Biosciences Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

530057

INE984E01035

1.12525

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

8.36

EPS(TTM)

Face Value()

Div & Yield %

Back

Challani Capital standalone net profit declines 79.49% in the December 2025 quarter

Feb 06,2026

Net profit of Challani Capital declined 79.49% to Rs 0.08 crore in the quarter ended December 2025 as against Rs 0.39 crore during the previous quarter ended December 2024. Sales declined 3.13% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 0.32 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.31	0.32	-3
OPM %	25.81	25.00	-
PBDT	0.08	0.39	-79
PBT	0.08	0.39	-79
NP	0.08	0.39	-79

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)